Aisling Capital Partners III LLC, 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), bought 908,565 shares at $12.50 ($5.0M) on 2016-07-06, disclosed to the SEC on 2016-07-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 508,565 | $0 | 0.0% |
| 2 | $12.50 | 400,000 | $5.0M | 100.0% |
| Total | $5.50 avg | 908,565 | $5.0M | 100% |
| Filing → |
| TTOO | BUY | 2015-12-09 | $3.0M | — | Filing → |
| LOXO | BUY | 2015-11-19 | $7.0M | — | Filing → |
| LOXO | BUY | 2015-11-16 | $2.2M | — | Filing → |